| Name | 5-Bromo-6-chloro-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one |
|---|---|
| Synonyms |
5-bromo-6-chloro-7-azaoxindole
5-Bromo-6-chloro-7-aza-2-oxindole 2H-Pyrrolo[2,3-b]pyridin-2-one, 5-bromo-6-chloro-1,3-dihydro- 5-bromo-6-chloro-3-phenylpyridazine 5-Bromo-6-chloro-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one bromochlorophenylpyridazine 2H-Pyrrolo[2,3-b]pyridin-2-one,5-bromo-6-chloro-1,3-dihydro- |
| Density | 1.9±0.1 g/cm3 |
|---|---|
| Boiling Point | 408.7±45.0 °C at 760 mmHg |
| Molecular Formula | C7H4BrClN2O |
| Molecular Weight | 247.477 |
| Flash Point | 201.0±28.7 °C |
| Exact Mass | 245.919540 |
| PSA | 45.48000 |
| LogP | 2.99 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.644 |
|
~%
297757-11-0 |
| Literature: Glaxo Wellcome Inc. Patent: US6350747 B1, 2002 ; Location in patent: Page column 70-71 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |